Medtronic, Inc. (MDT) PT Raised to $145 at UBS

May 28, 2021 8:29 AM

UBS analyst Matthew Taylor raised the price target on Medtronic, Inc. (NYSE: MDT) to $145.00 (from $135.00) while maintaining a Buy rating.

No results found